Taiho Pharmaceutical to Buy Araris Biotech for Initial $400M
By Daniella Parra Taiho Pharmaceutical said it will acquire Araris Biotech, a leader in antibody...
By Daniella Parra Taiho Pharmaceutical said it will acquire Araris Biotech, a leader in antibody...
By Karen Roman Vivani Medical, Inc. (Nasdaq: VANI) announced it finished the placement of NPM-115,...
By Karen Roman Vivani Medical, Inc. (Nasdaq: VANI) said it expects to spin off Cortigent,...
By Karen Roman Biopharmaceutical company Medera Inc. said it finished patient dosing in the trial...
By Daniella Parra Ascentage Pharma (NASDAQ: AAPG; HKEX) said that its drug Olverembatinib is the...
By Karen Roman Medical tech company Nano-X Imaging Ltd. (Nasdaq: NNOX) said Nanox.ARC, its digital...
By Daniella Parra Jeito Capital said it invested in Callio Therapeutics’ $187M Series A round...
By Karen Roman Biopharmaceutical company ReAlta Life Sciences said it appointed Andrew Miller, Ph.D., to...
By Daniella Parra March Biosciences was granted an orphan drug designation from the FDA to...
By Daniella Parra Lisata Therapeutics said results from Cohort A of its Phase 2 ASCEND...